{"transactions":[{"id":2221277,"issuer":{"id":8108,"kind":"organization","name":"Ensysce Biosciences, Inc."},"owners":[{"id":125850,"kind":"person","name":"Rauch Lee M.","position":1,"cik":"0001815345","reported_name":"Rauch Lee M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-06-27T17:41:23.000Z","date":"2022-06-23","kind":"grant","acquired":true,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On June 23, 2022, Ms. Rauch was granted an option (the \"Stock Option\") to purchase 15,000 shares of common stock of Ensysce Biosciences, Inc. (the \"Company\"), par value $0.0001 per share, with a per share exercise price of $0.425, under the Amended and Restated 2021 Omnibus Incentive Plan of the Company. The Stock Option vests 1/12th per month over one year."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 23, 2022, Ms. Rauch was granted an option (the \"Stock Option\") to purchase 15,000 shares of common stock of Ensysce Biosciences, Inc. (the \"Company\"), par value $0.0001 per share, with a per share exercise price of $0.425, under the Amended and Restated 2021 Omnibus Incentive Plan of the Company. The Stock Option vests 1/12th per month over one year."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On June 23, 2022, Ms. Rauch was granted an option (the \"Stock Option\") to purchase 15,000 shares of common stock of Ensysce Biosciences, Inc. (the \"Company\"), par value $0.0001 per share, with a per share exercise price of $0.425, under the Amended and Restated 2021 Omnibus Incentive Plan of the Company. The Stock Option vests 1/12th per month over one year."}],"balance_after":35000,"derivative":{"exercise_price":0.425,"expiration_date":"2032-06-23","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001493152-22-017877","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815345/000149315222017877/ownership.xml","form_type":"4"}},{"id":2904644,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":125850,"kind":"person","name":"Rauch Lee M.","position":1,"cik":"0001815345","reported_name":"Rauch Lee M.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-01-19T20:04:14.000Z","date":"2021-01-18","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in equal monthly installments over the following 6 months, subject to the Reporting Person's continued service to Issuer through each vesting date."}],"balance_after":15000,"derivative":{"exercise_price":23.03,"expiration_date":"2031-01-17","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000899243-21-002402","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815345/000089924321002402/doc4.xml","form_type":"4"}},{"id":3028784,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":125850,"kind":"person","name":"Rauch Lee M.","position":1,"cik":"0001815345","reported_name":"Rauch Lee M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (right to buy)","published_at":"2020-09-17T17:31:52.000Z","date":"2020-09-13","kind":"grant","acquired":true,"shares":900000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This amended Form 4 is being filed to correct the date of grant and related terms."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant to the Reporting Person of a stock option under the Issuer's 2016 Equity Incentive Plan (the \"Plan\"). The shares vest in 48 equal monthly\ninstallments beginning on October 13, 2020, provided that at the relevant vesting dates the Reporting Person's continuous service to the Issuer\nhas not been terminated as defined in and as determined under the Plan. The shares underlying the option are subject to accelerated vesting\nupon the occurrence of specified events including a change of control of the Issuer and the Reporting Person's termination. The option expires\nten years after the date of grant."}],"balance_after":900000,"derivative":{"exercise_price":0.9087,"exercise_date":"2020-10-13","expiration_date":"2020-09-12","underlying":"Common Stock","underlying_shares":900000},"source":{"system":"sec-edgar","filing":"0001209191-20-050986","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815345/000120919120050986/doc4a.xml","form_type":"4/A","original_submission_date":"2020-09-15"}},{"id":3031530,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":125850,"kind":"person","name":"Rauch Lee M.","position":1,"cik":"0001815345","reported_name":"Rauch Lee M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (right to buy)","published_at":"2020-09-15T21:45:38.000Z","date":"2020-09-14","kind":"grant","acquired":true,"shares":900000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant to the Reporting Person of a stock option under the Issuer's 2016 Equity Incentive Plan (the \"Plan\"). The shares vest in 48 equal monthly installments beginning on October 14, 2020, provided that at the relevant vesting dates the Reporting Person's continuous service to the Issuer has not been terminated as defined in and as determined under the Plan. The shares underlying the option are subject to accelerated vesting upon the occurrence of specified events including a change of control of the Issuer and the Reporting Person's termination. The option expires ten years after the date of grant."}],"balance_after":900000,"derivative":{"exercise_price":0.9087,"exercise_date":"2020-10-14","expiration_date":"2030-09-13","underlying":"Common Stock","underlying_shares":900000},"source":{"system":"sec-edgar","filing":"0001209191-20-050617","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815345/000120919120050617/doc4.xml","form_type":"4"}}]}